KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Finished Goods (2016 - 2025)

Historic Finished Goods for Acadia Pharmaceuticals (ACAD) over the last 10 years, with Q3 2025 value amounting to $25.0 million.

  • Acadia Pharmaceuticals' Finished Goods rose 3083.8% to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 3083.8%. This contributed to the annual value of $20.5 million for FY2024, which is 30913.82% up from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Finished Goods stood at $25.0 million for Q3 2025, which was up 3083.8% from $23.4 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Finished Goods ranged from a high of $25.0 million in Q3 2025 and a low of $947000.0 during Q1 2021
  • Its 5-year average for Finished Goods is $8.6 million, with a median of $2.1 million in 2021.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Finished Goods crashed by 6091.62% in 2021 and then soared by 75853.29% in 2024.
  • Quarter analysis of 5 years shows Acadia Pharmaceuticals' Finished Goods stood at $1.1 million in 2021, then soared by 72.89% to $1.9 million in 2022, then surged by 159.66% to $5.0 million in 2023, then skyrocketed by 309.14% to $20.5 million in 2024, then increased by 22.32% to $25.0 million in 2025.
  • Its last three reported values are $25.0 million in Q3 2025, $23.4 million for Q2 2025, and $23.9 million during Q1 2025.